Showing results (31-40 of 53) with videos related to
Sort By:
Pageof 6
The AAPS Journal|December 18, 2013
Assay formats: Recommendation for best practices and harmonization from the global bioanalysis consortium harmonization teamSherri Dudal, Daniel Baltrukonis, Rebecca Crisino, et al.Journal of Clinical Pharmacology|September 5, 2014
Pharmacokinetics, pharmacodynamics, and safety of peginterferon beta-1a in subjects with normal or impaired renal functionXiao Hu, Ali Seddighzadeh, Scott Stecher, et al.The Journal of Pharmacology and Experimental Therapeutics|June 22, 2011
In vivo pharmacology and toxicology evaluation of polyethylene glycol-conjugated interferon beta-1aXiao Hu, Kenneth Olivier, Evelyne Polack, et al.Plos One|November 19, 2014
Lymphotoxin-LIGHT pathway regulates the interferon signature in rheumatoid arthritisJadwiga Bienkowska, Norm Allaire, Alice Thai, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 7, 2013
Changes to anti-JCV antibody levels in a Swedish national MS cohortClemens Warnke, Ryan Ramanujam, Tatiana Plavina, et al.Journal of Clinical Pharmacology|June 18, 2011
A novel PEGylated interferon beta-1a for multiple sclerosis: safety, pharmacology, and biologyXiao Hu, Larisa Miller, Sandra Richman, et al.Molecular Therapy. Methods & Clinical Development|November 19, 2020
Investigational Assay for Haplotype Phasing of the Huntingtin GeneNenad Svrzikapa, Kenneth A Longo, Nripesh Prasad, et al.Annals of Neurology|August 26, 2010
Anti-JC virus antibodies: implications for PML risk stratificationLeonid Gorelik, Michaela Lerner, Sarah Bixler, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|November 5, 2019
Neurofilament light levels are associated with long-term outcomes in multiple sclerosisJens Kuhle, Tatiana Plavina, Christian Barro, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 14, 2020
Temporal profile of serum neurofilament light in multiple sclerosis: Implications for patient monitoringPeter A Calabresi, Douglas L Arnold, Dipen Sangurdekar, et al.Pageof 6